Inflammation Detection
Total Trials
3
As Lead Sponsor
As Collaborator
0
Total Enrollment
3,020
NCT02243033
Phase II Laser Focal Therapy of Prostate Cancer
Phase: N/A
Role: Lead Sponsor
Start: May 31, 2016
Completion: Nov 30, 2036
NCT03373006
A Phase II Study to Evaluate Axumin PET/CT for Risk Stratification for Prostate Cancer
Phase: Phase 2
Start: Feb 27, 2018
Completion: Jan 30, 2020
NCT05423860
Phase I Human Analytics (HALO) Study
Start: Mar 16, 2022
Completion: Mar 31, 2037
Loading map...